ВестникНОМУС
.
Сборникматериалов
конкурса
литературных
обзоров
-2012
177
33. Nadal A, Alonso-Magdalena P, Soriano S et al. The pancreatic beta-cell as a
target of estrogens and xenoestrogens: Implications for blood glucose homeostasis
and diabetes.Mol Cell Endocrinol 2009; 304 (1–2): 63–8.
34. Nappi C, Di Spiezio Sardo A, Acunzo G et al. Effects of a low-dose and ultra-
low-dose combined oral contraceptive use on bone turnover and bonemineral density
in young fertile women: a prospective controlled randomized study. Contraception
2003; 67: 355–59.cc
35. Ness RB et al. Hormonal and barrier contraception and risk of upper genital tract
disease in the PID Evaluation and Clinical Health (PEACH) study. Am J Obstet
Gynecol 2001; 185 (1): 121–7.
36. Rabe T. Contraception— Update and Trends. J Reproduktionsmed Endokrinol
2010; 7: 18—38.
37. Rossouw JE, PrenticeRL,Manson JE et al. Postmenopausal hormone therapy and
risk of cardiovascular disease by age and years since menopause. JAMA 2007; 297
(13): 1465–77.
38. SeedM, Knopp RH. Estrogens, lipoproteins, and cardiovascular risk factors: an
update following the randomized placebo-controlled trials of hormone-replacement
therapy. CurrOpinLipidol 2004; 15 (4): 459–67.
39. Shuk-Mei Ho. Estrogen, Progesterone and Epithelial Ovarian Cancer.
ReproductiveBiology andEndocrinology2003, 1:73 doi:10.1186/1477-7827-1-73
40. Shulman L et al. Return to fertility after use of reversible contraception.
DialoguesContracept 2006; 10: 1–3.
41. Speroff L., FritzM.A. Clinical gynecologic endocrinology and infertility. Seventh
edition. Chapter 2: hormone biosinthesis, methabolism, and mechanism of action.
LippincottWilliams&
Wilkins 2005; 25—97.
42. Stevenson JC, Rioux JE, Komer L, Gelfand M. 1 and 2 mg 17beta-estradiol
combined with sequential dydrogesterone have similar effects on the serum lipid
profile of postmenopausal women. Climacteric 2005; 8 (4): 352–9.
43.The Royal College of Obstetricians and Gynaecologists. The investigation and
management of endometriosis. Guideline 2000; 24.
44. Ushioda M, Makita K, Takamatsu K et al. Serum lipoprotein(a) dynamics
before/after menopause and long-term effects of hormone replacement therapy on
lipoprotein(a) levels in middle-aged and older Japanese women. HormMetab Res
2006; 38 (9): 581–6.
